MMB-2201

5F-AMB-PICA.svg

MMB-2201 is a synthetic cannabinoid that belongs to the indole-3-carboxamide family. It is a potent agonist of the cannabinoid receptors, specifically the CB1 and CB2 receptors. MMB-2201 is often used in scientific research to study the effects of cannabinoids on the human body and the endocannabinoid system.

Chemical Structure and Properties

MMB-2201 has a chemical structure that includes an indole core, which is a common feature among many synthetic cannabinoids. The full chemical name of MMB-2201 is (1-(5-fluoropentyl)-1H-indol-3-yl)(4-methyl-1-naphthoyl)methanone. The presence of a fluoropentyl chain and a naphthoyl group are characteristic features that contribute to its high affinity for cannabinoid receptors.

Pharmacology

MMB-2201 acts as a full agonist at both the CB1 and CB2 receptors. These receptors are part of the endocannabinoid system, which plays a crucial role in regulating various physiological processes, including pain sensation, mood, appetite, and memory. The activation of these receptors by MMB-2201 can lead to a range of effects, both therapeutic and adverse.

Legal Status

The legal status of MMB-2201 varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of accepted medical use. It is important to consult local regulations to determine the legality of MMB-2201 in a specific area.

Potential Risks and Side Effects

As with other synthetic cannabinoids, the use of MMB-2201 can pose significant health risks. Adverse effects may include tachycardia, hypertension, anxiety, paranoia, and hallucinations. In severe cases, it can lead to acute kidney injury and other life-threatening conditions. Due to these risks, the recreational use of MMB-2201 is strongly discouraged.

Research Applications

MMB-2201 is primarily used in scientific research to better understand the endocannabinoid system and the pharmacological effects of synthetic cannabinoids. Studies involving MMB-2201 can provide valuable insights into the development of new therapeutic agents for various medical conditions.

See Also

• Synthetic cannabinoids
• Cannabinoid receptor
• Endocannabinoid system
• CB1 receptor
• CB2 receptor